SLS Sellas Life Sciences Group Inc
Company Analysis
Latest News
🔴 Sellas Life Sciences is trading 7% down today as REGAL enters final analysis with results undisclosed
Sellas Life Sciences is trading 7.04% down at $9.67 as uncertainty ahead of the REGAL topline readout weighs on shares. - The Phase 3 REGAL trial reached its...
🔴 Sellas Life Sciences is trading 4.2% down today after REGAL trial triggered final analysis
Sellas Life Sciences is trading 4.2% lower at $9.94, with selling tied to its REGAL trial update and uncertainty ahead of topline results. - The October 28...
🟢 Sellas Life Sciences is trading 6% up
Sellas Life Sciences is trading at $10.99, up 5.88%, with no clear company-specific catalyst identified for the October 29 rebound. - Major U.S. indices are...
🔴 Sellas Life Sciences is trading 13.1% down as investors await blinded REGAL results
Sellas Life Sciences is trading 13.1% down at $10.58 as investors await preliminary topline results from its blinded Phase 3 REGAL trial. - On October 28, the...
🟢 Sellas Life Sciences rises 4.2% — Biotech Sector Rallies on Positive Clinical Trial Data and Regulatory News
With Biotech (XBI) up 2.2%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is trading higher today, driven by a...
🔴 Sellas Life Sciences is trading 5.6% down as technology-sector weakness weighs on broader markets
Sellas Life Sciences is trading at $11.49, down 5.6%, as broader markets sell off amid technology-sector weakness and geopolitical tensions. - The supplied...
🟢 Sellas Life Sciences is trading 10% up today amid broader biotech strength
Sellas Life Sciences is trading at $11.54, up 10.01%, amid stronger biotech-sector sentiment. - Biotech ETF XBI was reported up 2.10%, alongside industry M&A...
🟢 Sellas Life Sciences rises 4.4% — Biotech Sector Surges on M&A Activity and Positive Clinical Trial Data
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🟢 Sellas Life Sciences is trading 5% up today after CEO post fueled speculation about possible news
Sellas Life Sciences is trading at $10.46, up +4.81%, after CEO Angelos Stergiou’s October 19 anniversary post prompted retail speculation about possible...
🔴 Sellas Life Sciences is trading 12.96% down today ahead of high-risk Phase 3 REGAL readout
Sellas Life Sciences is trading at $9.87, down 12.96%, amid investor caution ahead of the high-risk Phase 3 REGAL readout and concerns over delayed results. -...
🔴 Sellas Life Sciences is trading 4.4% down
Sellas Life Sciences is trading 4.4% down at $10.84 on October 16, 2026, with no new company-specific announcement identified to explain the decline. - Recent...
🔴 Sellas Life Sciences is trading 4.04% down today with no clear catalyst identified
Sellas Life Sciences is trading 4.04% down at $11.40 on October 15, 2026, with no new company-specific catalyst reported. - Prior institutional-ownership...
SELLAS Shares Rise on Fund Buying Ahead of AML Trial Readouts
SELLAS Life Sciences shares rose in premarket trading Wednesday amid increased institutional ownership and anticipation of clinical trial results. The company...
🔴 Sellas Life Sciences is trading 4.43% down today after September inflation topped forecasts
Sellas Life Sciences is trading at $11.86, down 4.43%, as investors react to September CPI above forecasts. - Headline inflation was 3.7% year over year,...
🟢 Sellas Life Sciences is trading 5.3% up on October 13, 2026 with no confirmed explanation
Sellas Life Sciences is trading at $12.56, up 5.32%, with no confirmed explanation for the October 13 rise. - Investors are watching Phase 3 REGAL, reported...
🟢 Sellas Life Sciences rises 4.1% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🔴 Sellas Life Sciences is trading 4.11% down with no identified direct catalyst
Sellas Life Sciences is trading 4.11% down at $10.85 on October 8, 2026; no new company announcement directly explains the decline. - Coverage notes a fresh...
🔴 Sellas Life Sciences is trading 4.13% down with no clear company-specific catalyst
Sellas Life Sciences is trading 4.13% down at $11.15, with no clear company-specific announcement identified to explain the decline. - Available search...
🟢 Sellas Life Sciences is trading 5% up today as weak payrolls support risk-on sentiment
Sellas Life Sciences is trading at $11.88, up 4.90%, alongside a broad market advance as weak September payrolls supported a risk-on response. - Payrolls rose...
🔴 Sellas Life Sciences is trading 4.1% down today with no clear company-specific catalyst
Sellas Life Sciences is now trading 4.1% down at $11.80, with no new company-specific announcement identified to explain the October 1 decline. - Recent buyout...